arrow
返回
D

Debashis Sarker

king's college london

35H指数
341论文数
8.0K被引数
收录论文 81
发表时间
Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling早发性结直肠癌:临床与分子特征及全基因组分析提供的崭新见解
err2026-09-16
err0
errOAAI
errAmanda Nogueira; Jennifer Brondon; Konstantin Haradinov; Srinivasan Gopalakrishnan; Krane Huang; Debasri Mukherjee; Smita Agarwal; Kyle C. Strickland; Laura Vidal; Chinmayee Joshi; Rebecca Brookes; Rajeev Prasad; Soma Das; Arun K. Mankan; Archana Munje; Begona de las Heras; Brajendra Prasad Singh; Daniel Gandia; Shakti Ramkissoon; Fahmi Sabr Raza; Isagani Chico; Sharadchandra K. Prasad; Judith Perez; Anumeha Prasad; Debashis Sarker; Julien Taieb; Kamal S. Saini
err分享
err收藏
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework英国肿瘤药物研发:过去25年的分析及对2026年临床试验监管框架重启的关注
err2026-07-23
err0
errOAAI
errPaulina Czajka-Francuz; Chris Twelves; James Spicer; Archana Munje; Laura Vidal; Ruth Plummer; Dinesh Mistry; Maksym Novikov; Jim Bush; Gopalakrishnan Srinivasan; Soma Das; Sharan Sandhu; Vikram Bohra; Chinmayee Joshi; Ken Morrison; Suvarna Chavan; Fiona Thistlethwaite; Andrew Walding; Glen Clack; Michael George; Debashis Sarker; Raghib Ali; Sarah P. Blagden; Thomas R. Jeffry Evans; Kamal S. Saini
err分享
err收藏
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinomaNrf2介导的代谢重编程驱动肝细胞癌中调节性T细胞积累
err2026-07-13
err0
errOAAI
errE. Perpiñán; N. Sompairac; D. Marin Correa; E. Ramon-Gil; RCH Man; D. Camell-Raventos; R. Savoldelli; M. Fleming; L. Bellersheim; CX Santos; M. Elgosbi; JJ Lozano; M. Maddaloni; C. Schmidl; E. Kodela; M. Piqué-Gili; AH de Sande; R. Pinyol; S. Higginbotham; Q. Peng; E. Landman; J. Torres-Yaguana; V. Sharma; C. Zhang; A. Kurt; X. Liao; T. Dowe; M. Habarwaa; Z. Liu; Y. Zen; R. Miquel; D. Sarker; S. Kordasti; T. Tree; AM Shah; GO Fruhwirth; AT Dinkova-Kostova; EL Pearce; J. Leslie; JM Llovet; A. Sánchez-Fueyo; N. Safinia
err分享
err收藏
Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis2型糖尿病患者诊断前后常规测量生物标志物与胰腺癌风险之间的关联
errCancers
IF4.4
err2026-04-30
err0
errOAAI
errZiying Zhang; Sofia Carlsson; Niklas Hammar; Pilar Acedo; Beth Russell; Shahram Kordasti; Debashis Sarker; Mieke Van Hemelrijck; Aida Santaolalla
err分享
err收藏
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodologyExperimental Cancer Medicine Centre (ECMC)网络关于泛癌种测序的共识基因面板的提案:一种德尔菲方法
err2025-11-08
err0
errOAAI
errRichard Phillips; Bristi Basu; Zohra Butt; Mounia Beloueche; Natalie Cook; Simon J. Crabb; Alastair Greystoke; Darren Hargrave; Robert Jones; Muhammad Yasin Kureeman; Juanita Lopez; Claire McKeeve; Magdalena Meissner; Brent O’Carrigan; Eileen E. Parkes; Milind Ronghe; Patricia Roxburgh; Debashis Sarker; Kienan I. Savage; Paul H. S. Shaw; Stefan Symeonides; Deborah A. Tweddle; Aditi Vedi; Harriet S. Walter; Joanna Zabkiewicz; Gary W. Middleton; Andrew D. Beggs
err分享
err收藏
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinomaI期ADP-A2AFP TCR T细胞疗法在晚期肝细胞癌或胃肝样腺癌患者中的临床试验
err2025-08-12
err0
PREAI
errTim Meyer; Richard S. Finn; Mitesh Borad; Amit Mahipal; Julien Edeline; Roch Houot; Petr F. Hausner; Antoine Hollebecque; Lipika Goyal; Matthew Frigault; Thomas R. Jeffry Evans; Kit Man Wong; Benjamin R. Tan; Emmanuel Mitry; Debashis Sarker; Lynn Feun; Bassel El-Rayes; Fiona Thistlethwaite; Ahmed Kaseb; Olatunji Alese
err分享
err收藏
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumorsTIMEPOINT是一项将MTL-CEBPA与pembrolizumab联合使用的I期研究,证实了MTL-CEBPA在实体瘤中的免疫调节作用。
err2025-04-01
err0
errOAAI
errPlummer, Ruth; Sodergren, Mikael H.; Hodgson, Rose; Ryan, Brid M.; Raulf, Nina; Nicholls, Joanna P.; Reebye, Vikash; Voutila, Jon; Sinigaglia, Laura; Meyer, Tim; Pinato, David J.; Sarker, Debashis; Basu, Bristi; Blagden, Sarah; Cook, Natalie; Evans, Thomas R. Jeffrey; Yachnin, Jeffrey; Chee, Cheng E.; Li, Daneng; El-Khoueiry, Anthony; Diab, Maria; Huang, Kai-Wen; Pai, Madhava; Spalding, Duncan; Talbot, Thomas; Noel, Marcus S.; Keenan, Bridget; Mahalingam, Devalingam; Song, Min-Sun; Grosso, Melanie; Arnaud, Denis; Auguste, Aurelie; Zacharoulis, Dimitris; Storkholm, Jan; Mcneish, Iain; Habib, Robert; Rossi, John J.; Habib, Nagy A.
err分享
err收藏
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2
err2025-01-20
err0
errOAAI
errKocher, Hemant M.; Sasieni, Peter; Corrie, Pippa; McNamara, Mairead G.; Sarker, Debashis; Froeling, Fieke E. M.; Christie, Alan; Gillmore, Roopinder; Khan, Khurum; Propper, David
err分享
err收藏
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
err2024-10-01
err0
errOAAI
errPlummer, Ruth; Greystoke, Alastair; Naylor, Gregory; Sarker, Debashis; Anam, A. N. M. Kaiser; Prenen, Hans; Teuwen, Laure-Anne; Van Cutsem, Eric; Dekervel, Jeroen; Haugk, Beate; Ness, Thomas; Bhoi, Sujata; Jensen, Malene; Morris, Tom; Baumann, Pia; Sjogren, Niclas; Tunblad, Karin; Wallberg, Hans; Oberg, Fredrik; Evans, Thomas R. Jeffry
err分享
err收藏
Ramping up phase I trial recruitment: Defining potential barriers and disparities加速I期临床试验招募:界定潜在障碍与差异
err2024-09-01
err0
PREAI
errAktas, B. Y.; Morton, C.; Lee, A. J. X.; Josephs, D.; Kristeleit, R.; Sarker, D.; Spicer, J.
err分享
err收藏
err分享
err收藏
First-in-human, phase I/II, monotherapy, dose-escalation study of mRNA-4359, an mRNA-encoded PD-L1/IDO1 antigen-specific therapy, in advanced/refractory solid tumors首次人体研究,I/II期,单药治疗,剂量递增研究,针对mRNA-4359(一种mRNA编码的PD-L1/IDO1抗原特异性疗法)在晚期/难治性实体瘤中的应用
err2024-09-01
err4
PREAI
errKhattak, M. A.; Sullivan, R. J.; Gutierrez, M.; Jimeno, A.; Thomas, S. S.; Long, G. V.; Kummar, S.; Daud, A.; Rohatgi, A.; Sweis, R. F.; Bauman, J. E.; Boni, V.; Parakh, S.; Daghestani, H. N.; Xu, J.; Li, Y.; Morrissey, M.; Abadier, M.; Barlaskar, F.; Sarker, D.
err分享
err收藏
Final results of the first-in-human study of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in patients with advanced solid tumors
err2024-04-05
err0
PREAI
errCook, Natalie; Blagden, Sarah; Lopez, Juanita; Sarker, Debashis; Greystoke, Alastair; Haris, Noor Md; Kazmi, Farasat; Anam, Kaiser; Franco, Ana Ortego; Pihlak, Rille; Goodwin, Louise; Wilson, David; Phillips, Caroline; Robertson, Jane; Timmis, Helen; Tilston, Craig; Woodcock, Simon A.; Plummer, Ruth
err分享
err收藏
Unlocking Enhanced Immunity in Pancreatic Ductal Adenocarcinoma: Activins Interplay with CAF-Stroma Mechanisms
err2024-03-18
err0
PREAI
errMccluney, Simon; Park, Danielle; Miller, Daniel; Bloxham, Robert; Mehic, Merima; de Vries, Emma; Wang, Xuelu; Wilkinson, Robert; Hunt, James; Hyvonen, Marko; Boeing, Stefan; Sarker, Debashis; Hill, Caroline
err分享
err收藏
Neuroendocrine neoplasms: Consensus on a patient care pathway
err2024-03-12
err0
errOAAI
errHooper, Jessica; Jervis, Nikie; Morgan, Lucy; Beckett, Vivienne; Hand, Philippa; Higgs, Kate; Munir, Alia; Prinn, Jenny; Pritchard, D. Mark; Sarker, Debashis; Srirajaskanthan, Raj; Ellis, Catherine Bouvier
err分享
err收藏
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours
err2024-02-22
err7
PREAI
errClement, Dominique S. V. M.; van Leerdam, Monique E.; Tesselaar, Margot E. T.; Cananea, Elmie; Martin, Wendy; Weickert, Martin O.; Sarker, Debashis; Ramage, John K.; Srirajaskanthan, Rajaventhan
err分享
err收藏
A phase 1/2 study of dendrimer-enhanced (DEP) SN38 (SN38-SPL9111/DEP irinotecan) in patients with advanced solid tumours
err2023-12-01
err1
PREAI
errLiu, Jia; Minchom, Anna R.; Greystoke, Alastair; Evans, Thomas R. J.; Sarker, Debashis; Joshua, Anthony M.; Morton, Cienne; Gaus, Aisha; Yau, Wing; Cosman, Rasha; Chwialkowska, Dominika; Paull, Jeremy R. A.; Jean-Francois, Bernadette M.; Fairley, Jacinth K.; Main, Nicola J.; Edmondson, Stephanie R.; Cook, Natalie
err分享
err收藏
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cellsCD73控制变形虫胰腺癌细胞中肌球蛋白II驱动的侵袭,转移和免疫抑制
err2023-10-20
err6
errOAAI
errSamain, Remi; Maiques, Oscar; Monger, Joanne; Lam, Hoyin; Candido, Juliana; George, Samantha; Ferrari, Nicola; Kohihammer, Leonie; Lunetto, Sophia; Varela, Adrian; Orgaz, Jose L.; Vilardell, Felip; Olsina, Jorge Juan; Matias-Guiu, Xavier; Sarker, Debashis; Biddle, Adrian; Balkwill, Frances R.; Eyles, Jim; Wilkinson, Robert W.; Kocher, Hemant M.; Calvo, Fernando; Wells, Claire M.; Sanz-Moreno, Victoria
err分享
err收藏
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinomaNET-02: ni-iri/5-FU或多西他赛作为进行性低分化肺外神经内分泌癌患者二线治疗的随机,非比较,II期试验
err2023-06-01
err8
errOAAI
errMcNamara, Mairead G.; Swain, Jayne; Craig, Zoe; Sharma, Rohini; Faluyi, Olusola; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nick; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sothi, Sharmila; Anthoney, Alan; Bell, Christopher; Patel, Alkesh; Oughton, Jamie B.; Cairns, David A.; Mansoor, Wasat; Lamarca, Angela; Hubner, Richard A.; Valle, Juan W.
err分享
err收藏
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer
err2023-04-29
err18
errOAAI
errKristeleit, Rebecca; Plummer, Ruth; Jones, Robert; Carter, Louise; Blagden, Sarah; Sarker, Debashis; Arkenau, Tobias; Evans, Thomas R. Jeffry; Danson, Sarah; Symeonides, Stefan N.; Veal, Gareth J.; Klencke, Barbara J.; Kowalski, Mark M.; Banerji, Udai
err分享
err收藏